Literature DB >> 9237408

Trigeminal neuralgia. Clinical manifestations of first division involvement.

O Sjaastad1, J A Pareja, E Zukerman, J Jansen, P Kruszewski.   

Abstract

A series of 19 patients with what originally had been diagnosed as a first division (V1) trigeminal neuralgia was collected. The inclusion criteria were severe, rather short-lasting pain attacks within the V1 area, combined with trigger mechanisms. There were 10 women and 9 men, and the mean age of onset was 57.8 years. Fifteen of 16 with adequate information on attack duration had paroxysms of a "few seconds" duration or less, whereas 10 patients had paroxysms lasting < or = 2 seconds. In an exceptional case, only "more long-lasting" attacks (greater than 30 seconds' duration) were experienced. In regard to autonomic phenomena, lacrimation was most frequently present (in a total of 8 patients; 3 rather regularly, 5 more irregularly). The combination of lacrimation, conjunctival injection, and rhinorrhea was present in only 2 (of 19), and in neither of them in a major way. Typically, autonomic phenomena occurred during the later stages of disease and during particularly severe and long-lasting attacks. Seven of 14 with adequate information also had nocturnal attacks. Initially, a more or less complete carbamazepine effect was reported by 10 of 13 patients. Precipitation mechanisms were the same as with second and third division tic, but were mainly located within the V1 area, particularly initially. A comparison with SUNCT syndrome has been made. SUNCT is a predominantly male disorder, with only exceptional attacks of < or = 10 seconds' duration, and generally with attacks of 15 seconds or longer. Autonomic symptoms and signs are more pronounced than in V1 tic. Carbamazepine generally provides minor, if any, benefit in SUNCT. The present work strongly indicates that the two disorders are essentially different.

Entities:  

Mesh:

Year:  1997        PMID: 9237408     DOI: 10.1046/j.1526-4610.1997.3706346.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  13 in total

1.  Nummular headache update.

Authors:  Juan A Pareja; Teresa Montojo; Mónica Alvarez
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

2.  Defining neuralgiform headache with ipsilateral autonomic symptoms: case report in a headache center.

Authors:  Francesco De Cesaris; Marcello Fanciullacci; Umberto Pietrini; Bruno Anselmi; Enrico Del Bene
Journal:  Intern Emerg Med       Date:  2008-06-20       Impact factor: 3.397

Review 3.  MRI 3D CISS- A Novel Imaging Modality in Diagnosing Trigeminal Neuralgia - A Review.

Authors:  Radhika Besta; Y Uday Shankar; Ashwini Kumar; E Rajasekhar; S Bhanu Prakash
Journal:  J Clin Diagn Res       Date:  2016-03-01

Review 4.  Chronic orofacial pain.

Authors:  Rafael Benoliel; Yair Sharav
Journal:  Curr Pain Headache Rep       Date:  2010-02

Review 5.  Tic versus TAC: differentiating the neuralgias (trigeminal neuralgia) from the cephalalgias (SUNCT and SUNA).

Authors:  Juliana VanderPluym; Lawrence Richer
Journal:  Curr Pain Headache Rep       Date:  2015

Review 6.  SUNCT Syndrome: diagnosis and treatment.

Authors:  Juan A Pareja; Ana B Caminero; Ottar Sjaastad
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 7.  Nummular headache update.

Authors:  Daniel P Schwartz; Matthew S Robbins; Brian M Grosberg
Journal:  Curr Pain Headache Rep       Date:  2013-06

8.  SUNCT syndrome: The materialization of a headache syndrome.

Authors:  Ottar Sjaastad
Journal:  Clin Ophthalmol       Date:  2008-09

9.  SUNCT syndrome or first division trigeminal neuralgia associated with cerebellar hypoplasia.

Authors:  Alessandro Panconesi; Maria Letizia Bartolozzi; Leonello Guidi
Journal:  J Headache Pain       Date:  2009-09-16       Impact factor: 7.277

10.  Cardiovascular responses to cognitive stress in patients with migraine and tension-type headache.

Authors:  Rune B Leistad; Trond Sand; Kristian B Nilsen; Rolf H Westgaard; Lars Jacob Stovner
Journal:  BMC Neurol       Date:  2007-08-07       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.